Loading...
JNJ | ||
---|---|---|
OUTLOOK RATING 1..100 | 11 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 10 Undervalued | |
PROFIT vs RISK RATING 1..100 | 37 | |
SMR RATING 1..100 | 20 | |
PRICE GROWTH RATING 1..100 | 59 | |
P/E GROWTH RATING 1..100 | 86 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CURE | JNJ | |
---|---|---|
RSI ODDS (%) | 2 days ago90% | 2 days ago43% |
Stochastic ODDS (%) | 2 days ago90% | 2 days ago45% |
Momentum ODDS (%) | 2 days ago90% | 2 days ago51% |
MACD ODDS (%) | 2 days ago89% | 2 days ago29% |
TrendWeek ODDS (%) | 2 days ago90% | 2 days ago43% |
TrendMonth ODDS (%) | 2 days ago90% | 2 days ago42% |
Advances ODDS (%) | 2 days ago90% | 15 days ago43% |
Declines ODDS (%) | 12 days ago90% | 2 days ago45% |
BollingerBands ODDS (%) | 2 days ago90% | 2 days ago31% |
Aroon ODDS (%) | 2 days ago90% | 2 days ago30% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PAGDX | 85.96 | 1.87 | +2.22% |
Permanent Portfolio Aggressive Growth A | |||
PLGAX | 17.46 | 0.26 | +1.51% |
Principal LargeCap Growth I A | |||
AVUSX | 16.65 | 0.19 | +1.15% |
Avantis® U.S. Equity Institutional | |||
PMSGX | 6.69 | 0.05 | +0.75% |
Principal MidCap Growth R1 | |||
OSCCX | 19.54 | 0.07 | +0.36% |
Invesco Main Street Small Cap C |
A.I.dvisor indicates that over the last year, CURE has been loosely correlated with JNJ. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CURE jumps, then JNJ could also see price increases.
Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
---|---|---|---|---|
CURE | 100% | +1.02% | ||
JNJ - CURE | 58% Loosely correlated | -0.43% | ||
MRK - CURE | 57% Loosely correlated | -0.58% | ||
BDX - CURE | 57% Loosely correlated | -2.36% | ||
ELV - CURE | 56% Loosely correlated | +0.26% | ||
TMO - CURE | 56% Loosely correlated | +0.20% | ||
More |